Cresanto Global Ltd

Cresanto Global Ltd

BBSE:CRESANTO
5.37
INR
0.00
(0.00%)
-0.93EPS
20.84MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.13
0.13
Basic EPS, GAAP
-0.12
-0.04
-0.09
-0.12
-0.13
-0.12
-0.13
-0.16
-0.19
-0.4
-0.24
-0.42
-1.01
-0.93
Free Cash Flow per Basic Share
0.27
-0.07
0.01
- -
- -
- -
- -
- -
-5.16
-0.38
-0.14
-0.14
-1.11
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-4.01
-4.05
-4.14
-4.25
-4.39
-4.51
-4.64
-4.8
-5
-5.4
-5.63
-6.06
-7.06
- -
Tangible Book Value per Share
-4.01
-4.05
-4.14
-4.26
-4.39
-4.51
-4.64
-4.8
-5
-5.4
-5.63
-6.06
-7.06
- -
Basic Weighted Avg Shares
4
5
4
4
4
4
4
4
4
4
4
4
4
4
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-543.97
-482.56
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-1
-1
-1
-1
-2
-1
-2
-4
-4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-798.33
-736.73
Working Capital
-19
-19
-20
-20
-21
-21
-22
-22
-1
-1
-1
-2
-2
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
24
24
28
- -
Total Equity
-17
-17
-18
-18
-19
-19
-20
-21
-21
-23
-24
-26
-30
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
28
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
16
19
21

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
2
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.57%
8.11%
16.62%
Free Cash Flow
- -
- -
681.88%
Net Income, GAAP
37.16%
60.6%
138.39%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
1
- -
- -
1
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.04
-0.04
-0.58
0.16
-0.42
2026
-0.22
-0.02
-0.22
-0.55
-1.01
2027
-0.14
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Prashant Nathmal Bajaj
Full Time Employees
5
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Noida India
Business
Cresanto Global Limited, formerly known as Raymed Labs Limited, is an India-based diversified manufacturing, trading, and supply chain solutions enterprise operating across the flexible packaging, fast-moving consumer goods (FMCG), and consumer products sectors. The company specializes in the production, sourcing, import, export, and wholesale distribution of a wide portfolio of commercial and consumer merchandise; providing flexible packaging solutions, including multi-layer laminates, barrier films, plastic pouches, paper packaging materials, and specialty foils for food, beverage, industrial, and retail applications; supplying fast-moving consumer goods and personal care items, comprising soaps, face washes, oral care products, cosmetics, fragrances, and home care cleaning formulations; distributing confectionery and processed food products; marketing plastic articles and stationery supplies; and delivering integrated end-to-end services, such as contract manufacturing, private labeling, and brand management solutions for corporate clients. In recent developments, the company executed a significant strategic and operational transformation, shifting its primary business focus from legacy pharmaceutical manufacturing to high-growth flexible packaging, commercial trading, and FMCG supply chain services. As part of this comprehensive restructuring, the organization officially changed its name from Raymed Labs Limited to Cresanto Global Limited in April 2025 following board and shareholder approvals, transitioned leadership, and established a corporate office in Mumbai, Maharashtra, to expand its domestic distribution network and international trade footprint. Founded in 1992, Cresanto Global Limited is headquartered in Noida, Uttar Pradesh, India, with executive operations in Mumbai, Maharashtra, and is listed on the BSE under the scrip code 531207.